1. Home
  2. Analysis
  3. Zolpidem
  4. Dermatitis-exfoliative-generalised

Zolpidem and Dermatitis exfoliative generalised - a phase IV clinical study of FDA data

Summary:

Dermatitis exfoliative generalised is reported as a side effect among people who take Zolpidem (zolpidem tartrate), especially for people who are male, 60+ old, also take Fluvastatin, and have Myocardial ischaemia.

The phase IV clinical study analyzes which people have Dermatitis exfoliative generalised when taking Zolpidem. It is created by eHealthMe based on reports of 90,339 people who have side effects when taking Zolpidem from the FDA, and is updated regularly.

What is Zolpidem?

Zolpidem has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 92,695 Zolpidem users. Check the latest studies of Zolpidem.

What is Dermatitis exfoliative generalised?

Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface) is found to be associated with 263 drugs and 198 conditions by eHealthMe. Check the latest studies of Dermatitis exfoliative generalised.

On Jul, 26, 2026

90,339 people reported to have side effects when taking Zolpidem.
Among them, 14 people (0.02%) have Dermatitis exfoliative generalised.

Could Zolpidem cause Dermatitis exfoliative generalised?

Among these 14 people:

What is the gender of people who have Dermatitis exfoliative generalised when taking Zolpidem? *

  • female: 42.86 %
  • male: 57.14 %

What is the age of people who have Dermatitis exfoliative generalised when taking Zolpidem? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 7.69 %
  • 40-49: 7.69 %
  • 50-59: 7.69 %
  • 60+: 76.92 %

What are other drugs people take besides Zolpidem? *

  1. Fluoxetine: 5 people, 35.71%
  2. Fluvastatin: 5 people, 35.71%
  3. Pantoprazole: 3 people, 21.43%
  4. Coumadin: 3 people, 21.43%
  5. Acetaminophen: 2 people, 14.29%
  6. Lanoxin: 2 people, 14.29%
  7. Allopurinol: 2 people, 14.29%
  8. Oxycontin: 2 people, 14.29%
  9. Lasix: 2 people, 14.29%
  10. Lyrica: 1 person, 7.14%

What are other side effects people have besides Dermatitis exfoliative generalised? *

  1. Fever: 3 people, 21.43%
  2. Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 14.29%
  3. Stomatitis (inflammation of mucous membrane of mouth): 2 people, 14.29%
  4. Acute Kidney Failure: 2 people, 14.29%
  5. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 2 people, 14.29%
  6. Septic Shock (shock due to blood infection): 1 person, 7.14%
  7. Hypotension (abnormally low blood pressure): 1 person, 7.14%
  8. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 7.14%
  9. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 7.14%
  10. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 1 person, 7.14%

What are the existing conditions these people have? *

  1. Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 6 people, 42.86%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 14.29%
  3. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 14.29%
  4. Iron Deficiency: 1 person, 7.14%
  5. Back Pain: 1 person, 7.14%
  6. Bleeding Disorders: 1 person, 7.14%
  7. Cough: 1 person, 7.14%
  8. Fever: 1 person, 7.14%
  9. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 7.14%
  10. High Blood Pressure: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Zolpidem and have Dermatitis exfoliative generalised?

- Check whether Dermatitis exfoliative generalised is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zolpidem:

Dermatitis exfoliative generalised treatments and more:

How severe was Dermatitis exfoliative generalised and when was it recovered:

Expand to all the drugs that have ingredients of zolpidem tartrate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zolpidem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis exfoliative generalised:

Browse all the conditions that are associated with Dermatitis exfoliative generalised:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on zolpidem tartrate (the active ingredients of Zolpidem) and Zolpidem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.